Washington Legal Foundation
WLF requests that FDA be ordered to withdraw its March 16 Federal Register notice on off-label dissemination. The notice laid out FDA's interpretation of a Feb. 11 Washington, D.C. federal appeals court ruling that vacated portions of a July 1999 decision by Washington D.C. district court Judge Royce Lamberth enjoining FDA from restricting dissemination of off-label information (1"The Pink Sheet" March 20, p. 18). The notice suggests that the agency "is no longer restricted by the court's injunction" even though part of the injunction still stands, WLF maintains
You may also be interested in...
Uncertainty surrounding the federal appeals court decision in the Washington Legal Foundation v. Henney case likely benefits FDA, attorney Alan Bennett, (Bennett, Turner & Coleman), said.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials